We recently published a list of Top 10 AI News Updates Taking Wall Street By Storm. In this article, we are going to take a ...

Evercore ISI analyst Gavin Clark-Gartner maintained a Buy rating on Meiragtx Holdings (MGTX – Research Report) on March 14 and set a price ...

In a report released on March 14, Lisa Walter from RBC Capital maintained a Buy rating on Meiragtx Holdings (MGTX – Research Report), with a ...

MeiraGTx (NASDAQ:MGTX – Get Free Report) had its price objective raised by Royal Bank of Canada from $11.00 to $13.00 in a research note issued on Monday,Benzinga reports. The brokerage currently has ...

In this article, we are going to take a look at where MeiraGTx Holdings plc (NASDAQ:MGTX) stands against other top AI news updates taking Wall Street by storm. Escalating costs for developing ...

MeiraGTx (MGTX) stock gains as the company teams up with Hologen to form a JV to advance gene therapies for Parkinson's and other CNS diseases. Read more here.

MEIRAGTX HOLDINGS ($MGTX) posted quarterly earnings results on Thursday, March 13th. The company reported earnings of -$0.50 per share, beating estimates of -$0.57 by ...

Shares of MeiraGTx Holdings (NASDAQ:MGTX) traded higher in the premarket on Thursday after the company, with its Q4 2024 results, announced an agreement with AI-focused research firm Hologen ...

MeiraGTx (Nasdaq: MGTX) has entered into a strategic partnership with artificial intelligence firm Hologen to accelerate the ...

MeiraGTx and Hologen form a neuro-AI drug development joint venture, with up to $430M in funding to advance Parkinson's and CNS treatments.

Today announced strategic collaboration with Hologen AI, including a $200 million upfront payment to MeiraGTx and the formation of a joint venture, Hologen Neuro AI Ltd, with a further $230 million in ...